Success Story: NIW Approval for a Research Fellow Advancing Data-Driven Neurological Disease Research

Client’s Testimonial:

 

"Thanks for being highly professional, responsive, and supportive throughout the entire process. The petition and recommendation letters were very well prepared, communication was prompt and clear, and the overall experience exceeded my expectations. I truly appreciate the effort and guidance from the entire team."

 


 

On May 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Neurological Diseases (Approval Notice).

 


 

General Field: Neurological Diseases

 

Position at the Time of Case Filing: Research Fellow

 

Country of Origin: Egypt

 

State of Residence at the Time of Filing: Florida

 

Approval Notice Date: May 23rd, 2026

 

Processing Time: 1 month, 21 days (Premium Processing Requested)

 


 

Case Summary:

 

A research fellow from Egypt sought legal assistance from the North America Immigration Law Group (Chen Immigration Law Associates) for an NIW petition based on his work in neurological diseases. The client held an M.B.B.S. and had built a strong record in clinical research, neurological assessment, biomarker analysis, neuroimaging-based evaluation, and large-scale data modeling.

 

The petition focused on his proposed endeavor to improve the diagnosis, progression prediction, and treatment evaluation of dementia and related neurological disorders. Our team framed it around a broader national need: improving early detection, strengthening clinical decision-making, reducing the burden of neurodegenerative disease, and supporting better care for aging populations in the United States. The client’s credentials strongly supported this strategy. 

 

His record included 69 peer-reviewed journal articles, 11 conference abstracts, and 2 preprints. His publications had received 436 citations, with 6 papers ranked among the top 1%, 8 among the top 10%, and 10 among the top 20% most-cited Clinical Medicine articles for their publication years.

 

Our team also highlighted his peer-review service, including at least 30 completed reviews, as well as his editorial roles as a handling editor and editorial board member. His research had also been supported by National Institutes of Health funding, further reinforcing the national importance of his work in neurological and neurodegenerative disease research.

 

The petition was strengthened by expert support confirming the client’s ability to continue advancing research that improves clinical outcomes, patient safety, and biomedical innovation. USCIS approved the I-140 NIW petition on May 23, 2026, after only 1 month and 21 days under Premium Processing.

 

This outcome reflects NAILG’s careful presentation of a petition that connected the client’s clinical background, publication record, citation impact, peer-review service, and future research plans to broader U.S. interests in dementia research, neurological care, and public health innovation.